Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels (ITEM)
This study has been terminated.
( logistic reasons, patients could not be recruited )
Study NCT00559286   Information provided by RWTH Aachen University

First Received on November 15, 2007.   Last Updated on January 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Arterial Hypertension
Diabetes Mellitus Type 2 IRC or NIR
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 2
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Vascular Diseases
Interventions listed in this trial
Telmisartan
Additional drug interventions recognized in this trial
Angiotensin Receptor Antagonists
Antihypertensive Agents
Benzoates
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Anti-Infective Agents
Antifungal Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
RWTH Aachen University
CTCA
University of Heidelberg
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services